ReviewCureus2025
Trunnionosis After Total Hip Arthroplasty: A Review of the Etiology, Diagnosis, and Management.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prosthesis-Related Risk Factors for Trunnionosis: A Comprehensive Literature Review.Clinics in orthopedic surgery · 2026Review
- Case Report: Pseudotumor due to Trunnionosis in Ceramic-on-Ceramic THA Monoblock Acetabular Cup Disengagement.Case reports in orthopedics · 2026Article
- Symptomatic Periarticular Fluid Collection After Total Hip Arthroplasty: Septic or Aseptic Complication? A Case Report and Literature Review.Reports (MDPI) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trunnionosis implies wear and corrosion at the head-neck junction of the femoral component in a total hip replacement, leading to the release of metal ions and particulate debris. It has become a recognized complication following total hip arthroplasty (THA), particularly in modular implant designs. These wear processes can result in adverse local tissue reactions (ALTRs), implant loosening, and systemic effects in severe cases. Factors contributing to trunnionosis include implant design, patient anatomy, activity level, and surgical technique, all of which influence the degree of mechanical wear and corrosion at the taper interface. Clinical presentation is variable, ranging from localized pain and limp to systemic symptoms of metal hypersensitivity or toxicity. Diagnosis requires a comprehensive approach, integrating clinical evaluation, imaging studies such as magnetic resonance imaging (MRI), serum metal ion levels, and synovial fluid analysis to differentiate trunnionosis from infection and other causes of implant failure. Management strategies focus on revision surgery, involving debridement of ALTRs, exchange of the femoral head, and addressing implant instability or loosening. As the use of modular implants continues to rise, understanding the etiology, diagnosis, and management of trunnionosis is essential to improving outcomes for patients undergoing THA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.